view concern sever pressur point across
kmb busi incl neg price china weak consum
organ sale growth better-than-expect
conserv expect remain mute vs histor
trend peer pg remain concern
margin pressur ebit margin y/i
updat guidanc assum op margin growth
weaker previous anticip also feel better
current price environ given pg action product
convers retail worri price could end
promot back given recent share weak across sever
key categori all-in expect mike hsu bring
fresh perspect new role ceo effect
still cogniz mani cyclic structur headwind face kmb
op moreov sens management talk especi
given higher commod fx headwind higher tax rate
fact wouldnt surpris potenti
earn rebas next year mr hsu possibl set low bar
provid initi guidanc sales/ep well
kmb algorithm maintain market perform
ep albeit favor tax rate report
ep y/i although estimate lower-than-expect tax
like benefit ep
our/consensu est kmb organ sale growth slightli better-
expect vs conserv estimate driven
north america na consum product organ sale growth
sequenti improv vs
develop emerg market organ sale growth
also sequenti improv said overal
weak adj ebit margin y/i incl consum
tissu y/i focus reduc
cost everywher off-set higher input
cost all-in organ sale growth
ep guidanc remain unchang management
expect input cost inflat upper half prior
rang op profit growth closer
vs prior like off-set lower tax
rate vs low end rang prior lower
ep estim
china trend weak concern weak high
teen organ sale growth china larg reflect continu
price weak challeng market condit management
remain optimist kmb innov pipelin
health market increasingli concern competit
activ intensifi esp strong local competit
increasingli sophist
premium see reason optimist
china await evid turn becom posit
becom
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani data secur llc estim reuter
invest thesi attract categori geographi
current oper environ keep us cautiou
one largest consum product compani world strong portfolio highli
recogniz brand kleenex scott huggi pull-up kotex depend given strong
foothold mani key develop emerg market believ well posit capit
long-term expans growth spend power global middl class addit
optimist benefit long-term growth tailwind key categori adult
incontin matur develop market like unit state well emerg market
china continu gener cost save introduc greater level effici across
global oper particularli within suppli chain expect continu work
supplier upstream innov develop product value-accret compani
end user simultan lower input cost howev pressur mount kmb near-
term growth opportun given difficult price environ intensifi competit weaker
categori growth sever key market convict kmb emerg market
growth like rebound long term expect near-term emerg market growth remain
challeng bottom line time recoveri emerg market growth
uncertain believ prudent investor remain sidelin
ep ahead expect due mostli tax report ep
y/i our/consensu estim estim lower
expect tax rate benefit ep
kmb organ sale growth beat remain weak kmb company-wid organ sale
growth y/i our/consensu estim also
improv vs flat organ sale growth driven acceler develop emerg
market north america consum product organ sale growth improv y/i vs
develop emerg market organ sale growth improv vs
remain well dd growth recent final organ sale growth
slightli k-c profession develop market outsid na
organ sale growth in-lin estim sale north
america volum growth off-set pricing/mix volum hsd
infant child vs easi -msd y/i comp huggi volum msd driven
strong growth e-commerc benefit time promo innov meanwhil adult
volum -msd vs tough hsd y/i comp behind chang promo time
competit activ market organ sale growth solid volum flat
pricing/mix china organ sale high teen driven challeng
market condit increas competit activ volum lower price also
sharpli lose share brazil organ sale high-teen solid volum growth
diaper inflationary-driven price argentina organ sale also high-teen behind
fx-relat price offset weak volum eastern europ organ sale dd
straight quarter strong volum huggi kotex organ sale growth develop
market outsid na driven price
consum tissu organ sale growth slightli estim
north america sale vs growth year ago period weak
entir driven volum due lower promot activ price
innovation/de-sheet mix market organ sale growth flat volum
price/mix final organ sale growth develop market outsid north america
driven central europ balanc volum price
offset product mix consum tissu oper profit
y/i ebit margin driven higher pulp cost lower volum
k-c profession organ sale growth vs estim north
america organ sale slightli lsd volum growth washroom product wiper
off-set declin categori market organ sale growth driven
volum growth asia-pacif particularli strong final organ sale develop market
outsid north america flat product mix offset volum segment ebit
margin also pressur y/i driven commod fx headwind
china result remain concern organ sale growth china high-
teen worsen sequenti sale post strong
growth feminin off-set diaper sale sharpli
manag mention categori price diaper drop driven
competit activ manufactur greatli impact kmb result
offset volum growth hsd year-to-d increasingli belief kmb
innov pipelin may enough off-set continu competit threat includ local
competit becom increasingli sophist premium
price improv posit neg price last six quarter price
improv vs highest figur nearli year last
post price result benefit price latin america took
signific fx-relat price increas brazil argentina exampl manag note diaper
price argentina y/i especi encourag result
consid yet benefit recent price announc manag
announc msd hsd list price increas across major north america consum
product busi date convers retail product note
competit pg privat label also rais price expect strong benefit
recent announc price goe effect begin worri price
benefit could end promot back given kmb recent market share weak across sever
key categori
organ sale ep guidanc unchang manag continu expect
organ sale y/i ep fx headwind expect
headwind sale input cost inflat expect high end manag
rang all-in manag expect adjust oper incom declin high-
end slightli prior rang offset increment oper profit
headwind tax rate expect prior low-end
exhibit organ sale trend segment
note total organ sale growth data includ segment includ kc-profession across
geographi compani report nielsen xaoc includ c-store secur llc estim
note total person organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
note total consum tissu organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
quarterli consum tissu segment organ sale performanceconsum take-away retail vs manufactur shipment report nielsenreported/estimatedcorrel organ sale develop emerg market organ sale longer track deliv consist highsingl low-doubl digit organ growth believ could continu weigh investor sentiment -particularli trend deterior cosmet household person
exhibit categori result period end categori retail sale
note babi diaper china breakdown cover nielsen mass retail univers total china nation exclud
babi store babi diaper specialti breakdown babi store jf january/februari
nielsen scantrack total emerg market secur llc
exhibit emerg market valu sale volum average price per growth
note growth rate exclud brazil prior
nielsen scantrack total emerg market secur llc
exhibit emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
guidanc provid januari call april call juli call oct call fy sale sale py/up slightli y/yslightli higher previous impact salesneutr impact sale profitsadj op profit high end slightli growth ex-charg allocationcapit total capit allocationshar repurchas share repurchas defin benefit pension contributionsdividend itemsinput half rang pulp per metric y/yoil per y/ysav global restructur interest vs vs low incom equiti companiessimilar slightli vs vs lycash vs vs lyfi guidanc cosmet household person
price target base follow methodolog forward ev-to-ebitda price-to-earnings
analysi absolut rel discount analysi
forward ev-to-ebitda absolut rel current trade
ev/ebitda multipl discount compani histor averag
multipl discount compani histor averag multipl
price target impli ev/ebitda multipl discount
compani current ev/ebitda multipl discount histor averag multipl
discount histor averag multipl furthermor current trade
discount rel hpc peer group forward ev/ebitda multipl basi
guidanc provid januari call april call juli call oct call fy sale similar slightlysimilar sale slightlysimilar slightli like py/up slightli y/ysimilar py/down slightli y/ydown slightli impact improv vs prior profitsadj op profit translat end end growthex-charg drag/benefit allocationcapit end target total capit alloc repurchas dividend share repurchas share repurchas defin benefit pension contributionsup itemsinput pulp per metric per savingsat least least interest expensedown slightli y/ydown slightli y/ydown slightli vs lytax to/slightli lower improv vs prior vs lynet incom equiti companiesdown y/ydown vs lycash vs lycash convers day improv vs nice exceed day improv vs daysfi guidanc corpor
compar discount hpc group histor averag forward ev/ebitda
basi discount hpc group histor averag forward ev/ebitda basi
forward price-to-earnings absolut rel current trade price-to-earnings multipl
discount compani histor averag multipl
discount compani histor averag multipl price target impli
price-to-earnings multipl discount compani current price-to-earnings multipl
discount histor averag multipl discount histor
averag multipl furthermor current trade discount rel hpc peer
group forward price-to-earnings multipl basi compar discount hpc group
year histor averag forward price-to-earnings basi discount hpc group histor
sum-of-the-part discount also valu base sum-of-the-part dcf
analysi better understand compani growth opportun particularli person
k-c profession base analysi believ worth
segment worth consum tissu segment worth k-c
compani report secur llc estim
good sold- profit- research a- incom expens net- income- income- taxes- rate- equiti interests- net incom equiti companies- interest- income- eps- per net tissu net profession net sale ex research incom ex currenc incom k-c ep ex corpor
compani report secur llc estim
revenu build unless l/c sale profession sale ex-curr net sale incom total segment oper incom expens net- oper ex-charg sale growth sale growth ex-curr incom growth total segment oper net sale excl interseg incom segment oper incom segment oper margin cosmet household
price target nc
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ heighten competit pressur stronger dollar commod price volatil
strong develop emerg market footprint appear well posit capit long-
term expans spend power global rise middl class howev emerg market
categori growth moder competit pressur intensifi cautiou near term
base dalla tx one largest consum product compani world
lead brand kleenex scott huggi pull-up kotex depend hold
share posit countri sale
busi year sell brand countri
